| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Pancreatic Cancer Psychological Distress | Diagnostic Test: Barratt Simplified Measure of Social Status (BSMSS) Diagnostic Test: Global Assessment of Functioning scale (GAF) Diagnostic Test: General Self-Efficacy Scale (GSES) Diagnostic Test: Perceived Stress Scale (PSS) Diagnostic Test: Coping Orientation to Problems Experienced (Brief COPE), Diagnostic Test: Multidimensional Scale of Perceived Social Support (MSPSS) | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 150 participants |
| Allocation: | N/A |
| Intervention Model: | Single Group Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Diagnostic |
| Official Title: | Surveillance Program in High-risk Individuals for Pancreatic Cancer: Prospective Analysis of the Emotional Impact |
| Actual Study Start Date : | July 1, 2017 |
| Estimated Primary Completion Date : | July 31, 2021 |
| Estimated Study Completion Date : | December 31, 2021 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Psychometric assessment group
Arms to whom the psychometric assessment will be administered
|
Diagnostic Test: Barratt Simplified Measure of Social Status (BSMSS)
Questionnaire that evaluates cultural identity, educational level and occupation of the subject and the subject's parents and spouse (if any)
Diagnostic Test: Global Assessment of Functioning scale (GAF) Used to measure overall levels of functionality of an individual
Diagnostic Test: General Self-Efficacy Scale (GSES) Psychometric scale that is designed to assess optimistic self-beliefs to cope with a variety of difficult demands in life
Diagnostic Test: Perceived Stress Scale (PSS) To assess the perceived stress
Diagnostic Test: Coping Orientation to Problems Experienced (Brief COPE), It evaluates the subject's coping style through investigation of problem-solving abilities and emotional fluctuation, as a response to stressful situations
Diagnostic Test: Multidimensional Scale of Perceived Social Support (MSPSS) to explore the subject's social support system
|
| Ages Eligible for Study: | Child, Adult, Older Adult |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
| Italy | |
| University Hospital of Verona | |
| Verona, VR, Italy, 37134 | |
| Tracking Information | |||||
|---|---|---|---|---|---|
| First Submitted Date ICMJE | July 10, 2019 | ||||
| First Posted Date ICMJE | July 18, 2019 | ||||
| Last Update Posted Date | March 31, 2020 | ||||
| Actual Study Start Date ICMJE | July 1, 2017 | ||||
| Estimated Primary Completion Date | July 31, 2021 (Final data collection date for primary outcome measure) | ||||
| Current Primary Outcome Measures ICMJE |
|
||||
| Original Primary Outcome Measures ICMJE |
|
||||
| Change History | |||||
| Current Secondary Outcome Measures ICMJE | Not Provided | ||||
| Original Secondary Outcome Measures ICMJE | Not Provided | ||||
| Current Other Pre-specified Outcome Measures | Not Provided | ||||
| Original Other Pre-specified Outcome Measures | Not Provided | ||||
| Descriptive Information | |||||
| Brief Title ICMJE | The Emotional Impact of Surveillance for Pancreatic Cancer | ||||
| Official Title ICMJE | Surveillance Program in High-risk Individuals for Pancreatic Cancer: Prospective Analysis of the Emotional Impact | ||||
| Brief Summary | Due to its rarity a population screening program for pancreatic cancer is not possible. For this reason, considering background data on genetic predisposition and familiarity for this lethal tumor, efforts have been pushed to build up surveillance programs for subjects at high-risk of pancreatic cancer, due to familiarity and/or genetic predisposition. These programs are based on radiological examinations (such as MRI or endoultrasonography) and laboratory tests. However, little is known about the psychological burden of these programs. Only a handful of studies investigated, in various ways, how the participation in surveillance programs for pancreatic cancer may burden the psychological status, with a consequent possible impairment of the psychological wellbeing, and a higher risk of withdraw from the surveillance program itself. The aim of this study was to assess the psychological and emotional impact in high-risk individuals participating in a surveillance program for pancreatic cancer due to familiarity and/or to genetic predisposition, using specific psychological tools, such as multiple psychological questionnaires, investigating different functioning areas, administered by a clinical psychologist. | ||||
| Detailed Description | Not Provided | ||||
| Study Type ICMJE | Interventional | ||||
| Study Phase ICMJE | Not Applicable | ||||
| Study Design ICMJE | Allocation: N/A Intervention Model: Single Group Assignment Masking: None (Open Label) Primary Purpose: Diagnostic |
||||
| Condition ICMJE |
|
||||
| Intervention ICMJE |
|
||||
| Study Arms ICMJE | Experimental: Psychometric assessment group
Arms to whom the psychometric assessment will be administered
Interventions:
|
||||
| Publications * |
|
||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
| Recruitment Information | |||||
| Recruitment Status ICMJE | Active, not recruiting | ||||
| Actual Enrollment ICMJE |
150 | ||||
| Original Actual Enrollment ICMJE | Same as current | ||||
| Estimated Study Completion Date ICMJE | December 31, 2021 | ||||
| Estimated Primary Completion Date | July 31, 2021 (Final data collection date for primary outcome measure) | ||||
| Eligibility Criteria ICMJE |
Inclusion Criteria:
Exclusion Criteria:
|
||||
| Sex/Gender ICMJE |
|
||||
| Ages ICMJE | Child, Adult, Older Adult | ||||
| Accepts Healthy Volunteers ICMJE | Yes | ||||
| Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | ||||
| Listed Location Countries ICMJE | Italy | ||||
| Removed Location Countries | |||||
| Administrative Information | |||||
| NCT Number ICMJE | NCT04024345 | ||||
| Other Study ID Numbers ICMJE | Psy-FPC | ||||
| Has Data Monitoring Committee | No | ||||
| U.S. FDA-regulated Product |
|
||||
| IPD Sharing Statement ICMJE |
|
||||
| Responsible Party | Erica Secchettin, Azienda Ospedaliera Universitaria Integrata Verona | ||||
| Study Sponsor ICMJE | Azienda Ospedaliera Universitaria Integrata Verona | ||||
| Collaborators ICMJE | Not Provided | ||||
| Investigators ICMJE | Not Provided | ||||
| PRS Account | Azienda Ospedaliera Universitaria Integrata Verona | ||||
| Verification Date | March 2020 | ||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||